Glenmark Life Sciences Ltd. - Research Center
543322 GLS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 2,283.21 | 2,161.22 | 2,123.21 | 1,885.17 | 1,537.31 |
| Expenses | |||||
| Material consumed | 1,017.53 | 1,028.87 | 1,055.04 | 913.87 | 699.95 |
| Manufacturing expenses | 115.63 | 118.08 | 103.57 | 76.01 | 79.43 |
| Personnel expenses | 258.16 | 180.18 | 168.72 | 149.13 | 142.28 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 217.65 | 191.80 | 179.82 | 155.08 | 143.70 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 1,608.97 | 1,518.93 | 1,507.15 | 1,294.09 | 1,065.35 |
| Operating profit | 674.25 | 642.29 | 616.06 | 591.07 | 471.96 |
| Other recurring income | 12.04 | 28.96 | 14.70 | 0.81 | 11.99 |
| Adjusted PBDIT | 686.29 | 671.25 | 630.76 | 591.89 | 483.95 |
| Financial expenses | 1.55 | 0.55 | 27.96 | 87.55 | 33.52 |
| Depreciation | 53.45 | 42.09 | 37.88 | 33.39 | 29.37 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 631.29 | 628.61 | 564.93 | 470.94 | 421.07 |
| Tax charges | 160.40 | 161.65 | 146.20 | 119.36 | 107.97 |
| Adjusted PAT | 470.89 | 466.96 | 418.72 | 351.58 | 313.10 |
| Non recurring items | -5.46 | -0.29 | 0.10 | -0.53 | 0.47 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 465.43 | 466.67 | 418.82 | 351.06 | 313.57 |
| Earnigs before appropriation | 1,567.49 | 1,488.02 | 1,169.61 | 750.79 | 399.73 |
| Equity dividend | 275.69 | 385.96 | 128.65 | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 1,291.80 | 1,102.06 | 1,040.95 | 750.79 | 399.73 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis